Trial Profile
PHASE II STUDY OF 9-20-S-AMINO-CAMPTOTHECIN (9-AC) AS SECOND LINE THERAPY IN ADVANCED OVARIAN CARCINOMA
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs IDEC 132 (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- 11 Jan 2007 Status changed from in progress to completed.
- 17 Sep 2005 New trial record.